Industry
Cannabis prescriber Dr Sunny Nayee joins Akanda as medical director
Dr Nayee will focus on improving the level of care provided to medical patients in the UK.
Chronic pain expert and leading UK medical cannabis prescriber, Dr Sunny Nayee, has joined Akanda to focus on improving patient care.
International medical cannabis company, Akanda, has named chronic pain expert and experienced cannabis prescriber, Dr Sunny Nayee as its new UK medical director.
The appointment of Dr Nayee builds upon the company’s recent partnership with Cellen – the health tech company behind one of the UK’s first fully-digital pain clinics – in a bid to expand patient access to cannabis medicines.
In his role with Akanda, Dr Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.
Dr Nayee has been prescribing cannabis since 2019, and currently treats in excess of 1,000 patients.
Dr Sunny Nayee
He holds prizes from the NHS Strategic Health Authority’s innovation committee and Royal College of General Practitioners for work related to patient safety and has published research reviewing the safety and effectiveness of medical cannabis treatment for the treatment of chronic refractory pain.
He joins Akanda from the Lyphe Group, where he served as medical director.
Read more: Akanda – first UK company listing on NASDAQ with African operations
Dr Nayee commented: “My focus has always been on accurately diagnosing patients then giving them access to the best treatment options available.
“I’m excited to join up with Akanda and Cellen to play a fundamental role in helping to democratise access to medical cannabis for patients in need.”
Dr Nayee will be working closely with Cellen to enable Akanda to better address unmet healthcare needs of patients globally, starting with the UK.
Akanda recently signed a Memorandum of Understanding with the company, which will see the two work together to optimise medical cannabis supply chain activities across Cellen and Akanda business interests, to increase supply and choice for patients in the UK.
“It is an honour to welcome Dr Nayee to the Akanda team as we build the first seed-to-patient model, serving medical cannabis patients in the UK and Europe,” commented Tej Virk, Akanda’s CEO.
“Dr. Nayee is a renowned pain treatment expert with direct experience in cannabis therapies. This makes him the ideal face of Akanda for patients. I’m looking forward to having Dr Nayee by our side as we build a patient-oriented supply chain in the UK and eventually other international markets.”
For more industry news visit Cannabis Wealth
-
News4 months agoLuxembourg to Restrict Access to Medical Cannabis Flower on Prescription
-
News5 months agoNHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access
-
Epilepsy5 months agoUCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For
-
News6 months agoSpain’s proposed medical cannabis framework too ‘restrictive’, say patients
-
Health3 months agoUK IBD Patients Report Improvements With Medical Cannabis
-
News4 months agoGPs in Czech Republic Permitted To Prescribe Medical Cannabis From 2025
-
Health4 months agoCBD Shows Promise in Treatment of Endometriosis, Say Leading Women’s Health Researchers
-
News4 weeks agoClosing the Gap: How Real-World Evidence Could Reshape UK Medical Cannabis Policy
